Sanofi Proposes Christel Heydemann as Independent Director

Sanofi Outlines Strategic Priorities for Future Growth

Sanofi Proposes Christel Heydemann as Independent Director highlighting the company’s commitment to strengthening innovation, expanding its research pipeline, and delivering sustainable growth across its global pharmaceutical and vaccine businesses.

The company emphasized its continued focus on advancing breakthrough medicines and vaccines aimed at addressing critical healthcare needs worldwide. By leveraging its deep scientific expertise and expanding use of advanced technologies, Sanofi aims to accelerate the development of innovative treatments across key therapeutic areas.

Focus on Innovation and Research

Sanofi continues to prioritize research and development as a core driver of long‑term growth. The company is investing heavily in scientific innovation, particularly in areas such as immunology, rare diseases, vaccines, and specialty care.

Through its global R&D network, Sanofi is working to bring new therapies to patients while strengthening its pipeline with promising candidates that address complex and underserved medical conditions.

Strengthening Global Healthcare Impact

The company also reiterated its commitment to improving healthcare access worldwide. By combining advanced scientific research with strategic partnerships and digital innovation, Sanofi seeks to expand the reach of its treatments and vaccines to more patients across diverse markets.

Sanofi continues to collaborate with healthcare providers, governments, and research organizations to enhance public health outcomes and drive progress in global healthcare systems.

Positioning for Sustainable Growth

With a strong portfolio of medicines and vaccines, Sanofi remains focused on delivering long‑term value for patients, healthcare systems, and stakeholders. The company’s strategy centers on innovation, operational excellence, and expanding its presence in high‑growth therapeutic segments.

As the healthcare landscape evolves, Sanofi aims to remain at the forefront of scientific discovery while continuing to deliver impactful treatments that improve the lives of millions of people around the world.